Signal: CMR Surgical Raises $165m to continue development of surgical robot
Preview
Source: Pharmaceutical Technology
Isaac Hanson
Preview
Source: Pharmaceutical Technology
CMR Medical has now surpassed $1bn in capital funding. Photo: T. Schneider / Shutterstock.com.
Cambridge, UK-based CMR Surgical has raised $165m in funding to continue the development of its Versius surgical robot. This latest investment brings their total raised to over $1bn, cementing the coveted unicorn status the company acquired in 2019 through a £195m (then $240m) round of Series C funding.
CMR was founded in 2014, and through numerous record-breaking funding rounds has established itself as a major competitor of US-based Intuitive Surgery, currently the market leader in surgical robotics. It claims to offer a unique surgical experience by allowing complete freedom of port placement, mimicking the way surgeons would traditionally operate, alongside a modular system small enough to fit inside any operating theatre.
Recommended Reports
Preview
Source: Pharmaceutical Technology
ReportsLOA and PTSR Model - TAK-500 in Head And Neck Cancer Squamous Cell Carcinoma GlobalData
Preview
Source: Pharmaceutical Technology
ReportsLOA and PTSR Model - AVA-6000 in Head And Neck Cancer Squamous Cell Carcinoma GlobalData
View allCompanies IntelligenceC.M.R. SRLView all
Brian Hicks, Senior Medical Devices Analyst at GlobalData, explains that “Even well-established and leading robotic surgical companies like Intuitive Surgical continue to see near double-digit growth in this market overall, so investors see lots of potential in continued technological and product adoption into hospitals and integrated delivery networks.”
Versius recently passed the milestone of 15,000 surgeries and is used in over 20 countries across a range of specialisms. Alleged benefits of surgical robots include reduced strain for surgeons and decreased recovery times for patients by allowing for more widespread use of minimal access surgery (MAS).
MAS, commonly known as keyhole surgery, is a form of surgery in which the operation is performed through a series of small incisions in the body into which equipment is inserted, reducing blood loss and post-surgery pain and recovery time.
If CMR is able to continue to take market share from Intuitive Surgical, the growth potential is huge. Intuitive is currently valued at over $100bn and made more in profit last year than CMR has raised over its nine-year lifespan.
Our signals coverage is powered by GlobalData’s Thematic Engine, which tags millions of data items across six alternative datasets — patents, jobs, deals, company filings, social media mentions and news — to themes, sectors and companies. These signals enhance our predictive capabilities, helping us to identify the most disruptive threats across each of the sectors we cover and the companies best placed to succeed.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.